Skip to content

Clinical trials

Completed Brain Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Diseases Status: Completed Country / region: Australia Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20131
20162
20171
20184
20191
20202
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Neuroscience Trials Australia4
TauRx Therapeutics Ltd2
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.2
Alkahest, Inc.1
Inmune Bio, Inc.1
Takeda1
Varian, a Siemens Healthineers Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Diseases16
Central Nervous System Diseases11
Nervous System Diseases11
Neurodegenerative Diseases8
Parkinson Disease5
Cardiovascular Diseases4
Cerebrovascular Disorders4
Dementia4
Movement Disorders4
Parkinsonian Disorders4

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.